Full Text View
Tabular View
Study Results
Related Studies
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
This study has been completed.
Study NCT00325130   Information provided by Merck Sharp & Dohme Corp.

First Received on May 11, 2006.   Last Updated on October 29, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial